Aquestive Therapeutics
AQST
AQST
60 hedge funds and large institutions have $62M invested in Aquestive Therapeutics in 2021 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 11 increasing their positions, 23 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
13% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 24
28% less capital invested
Capital invested by funds: $86.3M → $62M (-$24.3M)
52% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 23
Holders
60
Holding in Top 10
1
Calls
$592K
Puts
$428K
Top Buyers
| 1 | +$1.74M | |
| 2 | +$974K | |
| 3 | +$862K | |
| 4 |
Morgan Stanley
New York
|
+$777K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$753K |
Top Sellers
| 1 | -$3.99M | |
| 2 | -$3.97M | |
| 3 | -$1.01M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$665K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$536K |